litlas
Log inCreate account

Val Gebski

Active 1987–2025

130
Papers
28,266
Citations
86
h-index
129
i10-index

Citations

Citations per year for Val Gebski1988: 3 citations1989: 3 citations1990: 6 citations1991: 9 citations1992: 14 citations1993: 11 citations1994: 15 citations1995: 12 citations1996: 14 citations1997: 19 citations1998: 22 citations1999: 32 citations2000: 37 citations2001: 35 citations2002: 44 citations2003: 50 citations2004: 43 citations2005: 50 citations2006: 68 citations2007: 76 citations2008: 80 citations2009: 80 citations2010: 86 citations2011: 132 citations2012: 109 citations2013: 126 citations2014: 153 citations2015: 153 citations2016: 151 citations2017: 190 citations2018: 243 citations2019: 1,051 citations2020: 1,075 citations2021: 967 citations2022: 745 citations2023: 526 citations2024: 820 citations2025: 320 citations2026: 6 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,515 citing papers, 19.6% of this breakdownChina: 1,147 citing papers, 8.9% of this breakdownUnited Kingdom: 888 citing papers, 6.9% of this breakdownItaly: 771 citing papers, 6% of this breakdownAustralia: 669 citing papers, 5.2% of this breakdownGermany: 633 citing papers, 4.9% of this breakdownFrance: 548 citing papers, 4.3% of this breakdownJapan: 533 citing papers, 4.2% of this breakdownNetherlands: 521 citing papers, 4.1% of this breakdownCanada: 517 citing papers, 4% of this breakdownSpain: 458 citing papers, 3.6% of this breakdownBelgium: 277 citing papers, 2.2% of this breakdown
0%19.6%Other 26.1%

Institutions

Fields

  • Medicine84.8%
  • Biochemistry, Genetics and Molecular Biology9%
  • Immunology and Microbiology0.8%
  • Neuroscience0.6%
  • Psychology0.5%
  • Health Professions0.5%
  • Other3.8%

Topics

  • Ovarian cancer diagnosis and treatment3.9%
  • Endometrial and Cervical Cancer Treatments3.7%
  • Lung Cancer Treatments and Mutations3.4%
  • PARP inhibition in cancer therapy3.4%
  • Cancer Immunotherapy and Biomarkers3.2%
  • Esophageal Cancer Research and Treatment2.8%
  • Other79.6%

Coauthors

All papers

Open in search
  1. Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

    Authors: Éric Pujade-Lauraine, Jonathan A. Ledermann, Frédèric Selle, Val Gebski, Richard T. Penson, Amit M. Oza, Jacob Korach, Tomasz Huzarski, Andrés Poveda, Sandro Pignata, Michael Friedländer, Nicoletta Colombo, Philipp Harter, Keiichi Fujiwara, Isabelle Ray‐Coquard, Susana Banerjee, Joyce F. Liu, Elizabeth Lowe, Ralph Bloomfield, Patricia Pautier, Jacob Korach, Tomasz Huzarski, Tomasz Byrski, Patricia Pautier, Michael Friedländer, Philipp Harter, Nicoletta Colombo, Sandro Pignata, Giovanni Scambia, Maria Ornella Nicoletto, Fiona Nussey, Andrew R. Clamp, Richard T. Penson, Amit M. Oza, A. Poveda Velasco, Manuel Rodrigues, Jean‐Pierre Lotz, Frédèric Selle, Isabelle Ray‐Coquard, Diane Provencher, Aleix Prat Aparicio, Laura Vidal Boixader, Clare L. Scott, Kenji Tamura, Mayu Yunokawa, Alla Lisyanskaya, Jacques Médioni, Nicolas Pécuchet, Coraline Dubot, Thibault De La Motte Rouge, Marie‐Christine Kaminsky, B. Weber, Alain Lortholary, Christine Parkinson, Jonathan A. Ledermann, Sarah Williams, Susana Banerjee, Jonathan A. Cosin, James Hoffman, Richard T. Penson, Marie Plante, Allan Covens, Gabe S. Sonke, Florence Joly, Anne Floquet, Susana Banerjee, Holger W. Hirte, Amnon Amit, Tjoung-Won Park-Simon, Koji Matsumoto, Sergei Tjulandin, Jae‐Hoon Kim, Laurence Gladieff, Roberto Sabbatini, David M. O’Malley, Patrick Timmins, Daniel Kredentser, Nuria Laínez Milagro, M.P. Barretina Ginesta, Ariadna Tibau Martorell, Alfonso Gómez de Liaño, Belén Ojeda González, Linda Mileshkin, Masaki Mandai, Ingrid Boere, Petronella B. Ottevanger, Joo‐Hyun Nam, Elias Abdo Filho, Salima Hamizi, Francesco Cognetti, David Warshal, Elizabeth Dickson-Michelson, Scott Kamelle, Nathalie D. McKenzie, Gustavo C. Rodriguez, Deborah K. Armstrong, Eva Chalas, Paul Celano, Kian Behbakht, Susan A. Davidson and 21 more - The Lancet Oncology 2017 cited by 1,863

  2. Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer

    Authors: Pedro T. Ramírez, Michael Frumovitz, René Pareja, Aldo López, Marcelo de Andrade Vieira, Reitan Ribeiro, Alessandro Buda, Xiaojian Yan, Yao Shuzhong, Naven Chetty, David Isla, Mariano Tamura, Tao Zhu, Kristy Robledo, Val Gebski, Rebecca Asher, Vanessa Behan, James Nicklin, Robert L. Coleman, Andreas Obermair - New England Journal of Medicine 2018 cited by 1,869

  3. Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial

    Authors: Gary Wittert, Karen Bracken, Kristy Robledo, Mathis Grossmann, Bu B. Yeap, David J. Handelsman, Bronwyn Stuckey, Ann J. Conway, Warrick J. Inder, Robert I. McLachlan, Carolyn A Allan, David Jesudason, Mark Ng Tang Fui, Wendy Hague, Alicia J. Jenkins, Mark Daniel, Val Gebski, Anthony Keech - The Lancet Diabetes & Endocrinology 2020 cited by 350

  4. Checkpoint Inhibitors in Metastatic EGFR- Mutated Non–Small Cell Lung Cancer—A Meta-Analysis

    Authors: Chee Khoon Lee, Johnathan Man, Sally Lord, Matthew Links, Val Gebski, Tony Mok, James Chih‐Hsin Yang - Journal of Thoracic Oncology 2016 cited by 845

  5. Effect of Laparoscopic-Assisted Resection vs Open Resection on Pathological Outcomes in Rectal Cancer

    Authors: Andrew R. L. Stevenson, Michael J. Solomon, John W. Lumley, Peter J. Hewett, Andrew D. Clouston, Val Gebski, Lucy Davies, Kate Wilson, Wendy Hague, John Simes - JAMA 2015 cited by 1,031

  6. Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial

    Authors: Linda Mileshkin, Kathleen N. Moore, Elizabeth H Barnes, Val Gebski, Kailash Narayan, Madeleine King, Nathan Bradshaw, Yeh Chen Lee, Katrina Diamante, Anthony Fyles, William Small, David K. Gaffney, Pearly Khaw, Susan A. Brooks, Joanna Thompson, Warner K. Huh, Cara Mathews, Martin Buck, Aneta Suder, Thomas E. Lad, Igor J. Barani, Christine H. Holschneider, Sylvia van Dyk, Michael Quinn, Danny Rischin, Bradley J. Monk, Martin R. Stockler - The Lancet Oncology 2023 cited by 190

  7. Clinical and Molecular Characteristics Associated With Survival Among Patients Treated With Checkpoint Inhibitors for Advanced Non–Small Cell Lung Carcinoma

    Authors: Chee Khoon Lee, Johnathan Man, Sally Lord, Wendy A. Cooper, Matthew Links, Val Gebski, Roy S. Herbst, Richard J. Gralla, Tony Mok, James Chih‐Hsin Yang - JAMA Oncology 2017 cited by 637

  8. SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma

    Authors: Pierce K. H. Chow, Mihir Gandhi, Say‐Beng Tan, Maung Win Khin, Ariunaa Khasbazar, Janus P. Ong, Su Pin Choo, Peng Chung Cheow, Chanisa Chotipanich, Kieron Lim, Laurentius A. Lesmana, Tjakra Wibawa Manuaba, Boon Koon Yoong, Aloysius Raj, Chiong Soon Law, Ian H.Y., Rolley Rey Lobo, Catherine Teh, Yun Hwan Kim, Yun Won Jong, Ho‐Seong Han, Si Hyun Bae, Hyun‐Ki Yoon, Rheun‐Chuan Lee, Chien‐Fu Hung, Cheng‐Yuan Peng, Po‐Chin Liang, Adam Bartlett, Kenneth Yuh Yen Kok, Choon Hua Thng, Albert Low, Anthony Soon Whatt Goh, Kiang Hiong Tay, Richard Lo, Brian K. P. Goh, David Chee Eng Ng, Ganesh Lekurwale, Wei Ming Liew, Val Gebski, Kenneth Mak, Khee Chee Soo, on behalf of Asia-Pacific Hepatocellular Carcinoma Trials Group - Journal of Clinical Oncology 2018 cited by 650

  9. Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup

    Authors: Ignace Vergote, Antonio González-Martı́n, Domenica Lorusso, Charlie Gourley, Mansoor Raza Mirza, Jean‐Emmanuel Kurtz, Aikou Okamoto, Kathleen N. Moore, Frédéric Kridelka, Iain A. McNeish, Alexander Reuß, Bénédicte Votan, Andreas du Bois, Sven� Mahner, I. L. Ray-Coquard, Elise C. Kohn, Jonathan S. Berek, David S.P. Tan, Nicoletta Colombo, Rongyu Zang, Nicole Concin, Dearbhaile M. O’Donnell, Alejandro Rauh-Hain, C. Simon Herrington, Christian Marth, Andrés Poveda, Keiichi Fujiwara, Gavin Stuart, Amit M. Oza, Michael A. Bookman, Sven� Mahner, Alexander Reuß, Andreas du Bois, Christoph Grimm, Christian Marth, Regina Berger, Nicole Concin, Ting‐Chang Chang, Kazunori Ochiai, Val Gebski, Alison Davis, Philip Beale, Ignace Vergote, Frédéric Kridelka, Hannelore Denys, Vincent Vandecaveye, Francisco José Cândido dos Reis, Maria Del Pilar Estevez-Diz, Gavin Stuart, Helen Mackay, Mark S. Carey, David Cibula, Pavel Dundr, Oliver Dorigo, Jonathan S. Berek, Dearbhaile M. O’Donnell, Feras Abu Saadeh, Ingrid Boere, Christianne Lok, Pluvio Coronado, Nelleke Ottevanger, David S.P. Tan, Joseph Ng, Antonio Gonzalez Martin, Ana Oaknin, Andrés Poveda, Alejandro Perez Fidalgo, Alejandro Rauh-Hain, Karen H. Lu, Carlos López-Zavala, Eva María Gómez-García, Isabelle Ray-Coquard, Xavier Paolettí, Jean‐Emmanuel Kurtz, Florence Joly, Bénédicte Votan, Michael A. Bookman, Kathleen Moore, Rebecca C. Arend, Keiichi Fujiwara, Hiroyuki Fujiwara, Kosei Hasegawa, Ilan Bruchim, Dalia Tsoref, Katsutoshi Oda, Aikou Okamoto, Takayuki Enomoto, Dayana Michel, Hee‐Seung Kim, Jung‐Yun Lee, Asima Mukhopadhyay, Dionyssios Katsaros, Nicoletta Colombo, Sandro Pignata, Domenica Lorusso, Giovanni Scambia, Elise C. Kohn, Jungmin Lee, Iain A. McNeish, Shibani Nicum and 16 more - The Lancet Oncology 2022 cited by 142

  10. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis

    Authors: Katrin Marie Sjoquist, Bryan Burmeister, B. Mark Smithers, John Zalcberg, R. J. Simes, Andrew P. Barbour, Val Gebski - The Lancet Oncology 2011 cited by 1,662

  11. Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition

    Authors: George Sharbeen, Joshua A. McCarroll, Anouschka Akerman, Chantal Kopecky, Janet Youkhana, John Kokkinos, Jeff Holst, Cyrille Boyer, Mert Erkan, David Goldstein, Paul Timpson, Thomas R. Cox, Brooke Pereira, Jessica L. Chitty, Sigrid K. Fey, Arafath K. Najumudeen, Andrew D. Campbell, Owen J. Sansom, Rosa Mistica C. Ignacio, Stephanie Naim, Jie Liu, Nelson Russia, Jungwha Lee, Angela Chou, Amber L. Johns, Anthony J. Gill, Estrella Gonzales‐Aloy, Val Gebski, Yi Fang Guan, Marina Pajic, Nigel Turner, Minoti V. Apte, Thomas P. Davis, Jennifer P. Morton, Koroush S. Haghighi, Jorjina Kasparian, Benjamin J. McLean, Yordanos F. Setargew, Phoebe A. Phillips - Cancer Research 2021 cited by 132

  12. Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse

    Authors: Éric Pujade-Lauraine, Uwe Wagner, Elisabeth Aavall-Lundqvist, Val Gebski, M. Heywood, P. Vasey, Birgit Volgger, Ignace Vergote, Sandro Pignata, Annamaria Ferrero, Jalid Sehouli, Alain Lortholary, Gunnar B. Kristensen, Christian Jackisch, Florence Joly, Chris Brown, Nathalie Le Fur, Andreas du Bois - Journal of Clinical Oncology 2010 cited by 572

  13. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double-blind, placebo-controlled trial

    Authors: William Clark, Paul Bird, Peter Gonski, Terrence Diamond, Peter Smerdely, H. Patrick McNeil, Glen Schlaphoff, Carl Bryant, Elizabeth H Barnes, Val Gebski - The Lancet 2016 cited by 440

  14. Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer

    Authors: Monika Janda, Val Gebski, Lucy Davies, Peta Forder, Alison H. Brand, Russell Hogg, Thomas W. Jobling, Russell Land, Tom Manolitsas, Marcelo Nascimento, Deborah Neesham, James Nicklin, Martin K. Oehler, Geoff Otton, Lewis Perrin, Stuart Salfinger, Ian Hammond, Yee Leung, Peter Sykes, Hys Ngan, Andrea Garrett, Michael Laney, Tong Yow Ng, Kar‐Fai Tam, Karen K. L. Chan, C. David Wrede, Selvan Pather, Bryony Simcock, Rhonda Farrell, Gregory Robertson, Graeme Walker, Nigel R Armfield, Nick Graves, Anthony J. McCartney, Andreas Obermair - JAMA 2017 cited by 418

  15. Disease-free Survival and Local Recurrence After Laparoscopic-assisted Resection or Open Resection for Rectal Cancer

    Authors: Andrew R. L. Stevenson, Michael J. Solomon, Chris Brown, John W. Lumley, Peter J. Hewett, Andrew D. Clouston, Val Gebski, Kate Wilson, Wendy Hague, John Simes - Annals of Surgery 2018 cited by 269

  16. Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-Analysis Collaboration

    Authors: Lisa Askie, Brian A. Darlow, Neil Finer, Barbara Schmidt, Ben J Stenson, William Tarnow‐Mordi, Peter G. Davis, Waldemar A. Carlo, Peter Brocklehurst, Lucy Davies, Abhik Das, Wade Rich, Marie G. Gantz, Robin S. Roberts, Robin K. Whyte, Lorrie Costantini, Christian F. Poets, Elizabeth Asztalos, Malcolm Battin, Henry L. Halliday, Neil Marlow, Win Tin, Andrew King, Edmund Juszczak, Colin J. Morley, Lex W. Doyle, Val Gebski, Kylie E Hunter, R. J. Simes - JAMA 2018 cited by 424

  17. Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study

    Authors: on behalf of the FIELD Study investigators, Timothy M. E. Davis, R. Ting, James D. Best, Mark W. Donoghoe, P. L. Drury, David Sullivan, Alicia J. Jenkins, Rachel O’Connell, M.J. Whiting, Paul Glasziou, R. John Simes, Y. Antero Kesäniemi, Val Gebski, Russell Scott, Anthony Keech - Diabetologia 2010 cited by 365

  18. LACC Trial: Final Analysis on Overall Survival Comparing Open Versus Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer

    Authors: Pedro T. Ramirez, Kristy Robledo, Michael Frumovitz, René Pareja, Reitan Ribeiro, Aldo López, Xiaojian Yan, David Isla, Renato Moretti‐Marques, Marcus Q. Bernardini, Val Gebski, Rebecca Asher, Vanessa Behan, Robert L. Coleman, Andreas Obermair - Journal of Clinical Oncology 2024 cited by 81

  19. Impact of Specific Epidermal Growth Factor Receptor (EGFR) Mutations and Clinical Characteristics on Outcomes After Treatment With EGFR Tyrosine Kinase Inhibitors Versus Chemotherapy in EGFR-Mutant Lung Cancer: A Meta-Analysis

    Authors: Chee Khoon Lee, Yi‐Long Wu, Pei Ni Ding, Sarah J. Lord, Akira Inoue, Caicun Zhou, Tetsuya Mitsudomi, Rafael Rosell, Nick Pavlakis, Matthew Links, Val Gebski, Richard J. Gralla, James Chih‐Hsin Yang - Journal of Clinical Oncology 2015 cited by 326

  20. Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival

    Authors: Chee Khoon Lee, Lucy Davies, Yi‐Long Wu, Tetsuya Mitsudomi, Akira Inoue, Rafael Rosell, Caicun Zhou, Kazuhiko Nakagawa, Sumitra Thongprasert, Masahiro Fukuoka, Sally Lord, Ian C. Marschner, Yu‐Kang Tu, Richard J. Gralla, Val Gebski, Tony Mok, James Chih‐Hsin Yang - JNCI Journal of the National Cancer Institute 2016 cited by 254

  21. Incidence of adverse events in minimally invasive vs open radical hysterectomy in early cervical cancer: results of a randomized controlled trial

    Authors: Andreas Obermair, Rebecca Asher, René Pareja, Michael Frumovitz, Aldo López, Renato Moretti‐Marques, Gabriel Jaime Rendón-Pereira, Reitan Ribeiro, Audrey Tieko Tsunoda, Vanessa Behan, Alessandro Buda, Marcus Q. Bernadini, Hongqin Zhao, Marcelo de Andrade Vieira, Joan L. Walker, Nick M. Spirtos, Shuzhong Yao, Naven Chetty, Tao Zhu, David Isla, Mariano Tamura, James Nicklin, Kristy Robledo, Val Gebski, Robert L. Coleman, Gloria Salvo, Pedro T. Ramírez - American Journal of Obstetrics and Gynecology 2019 cited by 142

  22. Immune checkpoint inhibitors in kidney transplant recipients: a multicentre, single-arm, phase 1 study

    Authors: Robert Carroll, Michael Boyer, Val Gebski, Bronwyn Hockley, Julie Johnston, Svjetlana Kireta, Hsiang Tan, Anne E. Taylor, Kate Wyburn, John Zalcberg - The Lancet Oncology 2022 cited by 87

  23. Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients

    Authors: David Sullivan, Anders Olsson, Robert C. Scott, Jae Bum Kim, Allen Xue, Val Gebski, Scott M. Wasserman, Evan A. Stein - JAMA 2012 cited by 448

  24. First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

    Authors: Harpreet Wasan, Peter Gibbs, Navesh Sharma, Julien Taı̈eb, Volker Heinemann, Jens Ricke, Marc Peeters, Michael Findlay, Andrew Weaver, Jamie Mills, Charles Wilson, Richard Adams, Anne Francis, Joanna Moschandreas, Pradeep S. Virdee, Peter Dutton, Sharon Love, Val Gebski, Alastair Gray, Richard Adams, Andrew Bateman, Claire Blesing, Ewan Brown, Ian Chau, Sebastian Cummins, David Cunningham, Stephen Falk, Maher Hadaki, Marcia Hall, Tamas Hickish, Joanne Hornbuckle, F. Lofts, Sarah Lowndes, Astrid Mayer, Matthew S. Metcalfe, Gary Middleton, Jamie Mills, Amir Montazeri, R. Muirhead, Andreas Polychronis, Colin Purcell, Paul J. Ross, Ricky A. Sharma, Liz Sherwin, David Smith, Rubin Soomal, Daniel Swinson, Axel Walther, Harpreet Wasan, Andrew Weaver, Charles Wilson, Greg Wilson, Pradip Amin, Bruna Angelelli, Jacques Balosso, Alex Beny, Daniel Bloomgarden, Evelyn Boucher, Michael D. Brown, Harald-Robert Bruch, James Bui, Matthew Burge, Giuseppe Cardaci, James Carlisle, Seungjean Chai, Yi‐Jen Chen, P. Chevallier, Michael Chuong, Stephen Clarke, Andrew L. Coveler, M Craninx, Thierry Delanoit, Amélie Deleporte, Paul Eliadis, Francis Facchini, Thomas W. Ferguson, Michel Ferrante, Michael Findlay, Gary Frenette, Jacob Frick, Vinod Ganju, Michael Garofalo, Karen Geboes, Gerald Gehbauer, Benjamin George, Ravit Geva, Peter Gibbs, Melita A. Gordon, Kate Gregory, Seza A. Güleç, James Hannigan, Guy van Hazel, Norman Heching, Volker Heinemann, Thomas Helmberger, Alain Hendlisz, Koen Hendrickx, Matthew P. Holtzman, Richard Isaacs, Christopher Jackson and 156 more - The Lancet Oncology 2017 cited by 398